Skip to main content
. 2022 Jul 12;21(2):1895–1901. doi: 10.1007/s40200-022-01086-0

Table 1.

Characteristics of included studies selected for meta-analysis

Author. Year of Publication Population Method Cases (n) Controls (n) Overall Sample Size Count (Genotype)
Diabetic Nondiabetic (Control)
GG TG TT GG TG TT
Joshaghani et al. 2020 Iranian PCR-RFLP 211 202 413 18 77 116 5 48 149
Sánchez et al. 2019 Venezuelan PCR-RFLP 46 44 90 1 4 41 2 12 30
Nam JS 2018 Korean PCR 249 131 380 119 108 22 61 60 10
Hussain et al. 2018 Iraqi PCR-RFLP 400 400 800 33 110 257 8 78 314
Momin AA 2017 Indian PCR 150 150 300 2 21 127 0 6 144
Sheng T 2016 Korean Chinese PCR 191 138 329 13 81 97 9 63 66
Saleh R 2016 Bangladeshi PCR-RFLP 55 40 95 3 19 33 1 12 27
Farooq,R 2018 Indian PCR-RFLP 400 300 700 40 168 192 24 123 153
Vendramini, M.F. 2010 Japanese Brazilians PCR 200 200 400 12 95 93 15 85 100
Potapov,V.A. 2008 Russian PCR 129 117 246 2 10 117 1 8 108
Lee,Y.Y. 2005 Korean PCR 493 427 920 39 202 252 45 181 201
Al Hannan, F.A. 2016 Bahraini PCR-RFLP 140 66 206 8 32 100 10 0 56
Ming-Kai Tsa 2014 Taiwan’s Chinese Han PCR 149 139 288 9 69 71 12 57 70
Amal et al. 2014 Egyptian PCR-RFLP 296 209 505 34 145 117 10 78 121
Saxena et al. 2012 North Indian PCR-RFLP 221 205 426 23 55 143 11 46 148
Fatemeh Namvaran 2012 Iranian PCR 101 128 229 3 31 67 6 21 101